Correlation Between GlaxoSmithKline PLC and AcelRx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and AcelRx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and AcelRx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and AcelRx Pharmaceuticals, you can compare the effects of market volatilities on GlaxoSmithKline PLC and AcelRx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of AcelRx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and AcelRx Pharmaceuticals.
Diversification Opportunities for GlaxoSmithKline PLC and AcelRx Pharmaceuticals
-0.85 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GlaxoSmithKline and AcelRx is -0.85. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and AcelRx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AcelRx Pharmaceuticals and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with AcelRx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AcelRx Pharmaceuticals has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and AcelRx Pharmaceuticals go up and down completely randomly.
Pair Corralation between GlaxoSmithKline PLC and AcelRx Pharmaceuticals
Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.21 times more return on investment than AcelRx Pharmaceuticals. However, GlaxoSmithKline PLC ADR is 4.86 times less risky than AcelRx Pharmaceuticals. It trades about 0.02 of its potential returns per unit of risk. AcelRx Pharmaceuticals is currently generating about -0.06 per unit of risk. If you would invest 3,193 in GlaxoSmithKline PLC ADR on August 31, 2024 and sell it today you would earn a total of 240.00 from holding GlaxoSmithKline PLC ADR or generate 7.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 28.51% |
| Values | Daily Returns |
GlaxoSmithKline PLC ADR vs. AcelRx Pharmaceuticals
Performance |
| Timeline |
| GlaxoSmithKline PLC ADR |
| AcelRx Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
GlaxoSmithKline PLC and AcelRx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GlaxoSmithKline PLC and AcelRx Pharmaceuticals
The main advantage of trading using opposite GlaxoSmithKline PLC and AcelRx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, AcelRx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AcelRx Pharmaceuticals will offset losses from the drop in AcelRx Pharmaceuticals' long position.| GlaxoSmithKline PLC vs. Novartis AG ADR | GlaxoSmithKline PLC vs. AstraZeneca PLC ADR | GlaxoSmithKline PLC vs. Roche Holding Ltd | GlaxoSmithKline PLC vs. Bristol Myers Squibb |
| AcelRx Pharmaceuticals vs. Lifecore Biomedical | AcelRx Pharmaceuticals vs. Shuttle Pharmaceuticals | AcelRx Pharmaceuticals vs. Catalent | AcelRx Pharmaceuticals vs. Tilray Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |